Q3 2020
Released Oct 20, 2020, before the open
10-Q filed Oct 29, 2020, 29 days after period end · 0001653477-20-000082
Q3 2020 · 10-Q
Revenue$331.70M$331.70M −7.8% vs Q3 2019+22.6% vs Q2 2020
Net Income$69.90M$69.90M +16.7% vs Q3 2019+246.0% vs Q2 2020
EPS Diluted$1.69$1.69 +19.9% vs Q3 2019+244.9% vs Q2 2020
Gross Profit$139,600,000+0.1%
Operating Income$127,600,000+11.9%
Operating Cash Flowderived$90,000,000−24.2%
Free Cash Flowderived$73,500,000−23.9%
Margins · derived
Gross margin42.1%+3.3 pt vs Q3 2019
Operating margin38.5%+6.8 pt vs Q3 2019
Net margin21.1%+4.4 pt vs Q3 2019
What the release said
The release
Same quarter
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $331.70M | $359.90M | $311.20M | $264.10M |
| Net Income | $69.90M | $59.90M | $49.50M | $33.80M |
| EPS Diluted | $1.69 | $1.41 | $1.16 | $0.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR